Nyrada Inc (ASX:NYR) Advances Phase I Clinical Trial to Third Cohort
Nyrada Inc (ASX:NYR) progresses its Phase I clinical trial to the third cohort, with final readouts expected in Q3 2025.
Category: ASX-NYR
Nyrada Inc.
Nyrada Inc. (ASX:NYR) Progresses Phase I Clinical Trial
Nyrada Inc. (ASX:NYR) advances its Phase I clinical trial to the second cohort, anticipating final readouts in Q3 CY2025.